ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Zoster vaccine

  • Font size: Larger Smaller
  • Hits: 4453
  • Print

Herpes zoster is a common condition especially in our aging cohort.  There is limited information about the use of HZ vaccine in this group.  Paper 96 presented results from a randomised, double-blind, placebo-controlled trial assessing safety and immunogenicity of 2 doses of ZV in HIV+ adults ≥18 years old (CD4 >200 copies/µL; HIV RNA  Preliminary data suggest that the vaccine is generally safe, and immunogenic. Further data from this study is awaited.

 

 

 

Tagged in: CROI2012
  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Sunday, 09 August 2020

Upcoming webinar: Thursday 13 August, 5:30 pm - 6:30 pm AEST. The webinar will be available via Zoom, and will incl… https://t.co/3b5aVq1R03

ASHM ASHM

The REACH-C online form is an important tool that links practitioners not experienced in the treatment of hepatitis… https://t.co/lh8sXaEzPu

ASHM ASHM